KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Change in Cash (2018 - 2025)

Historic Change in Cash for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$182.5 million.

  • BioNTech SE's Change in Cash rose 7893.67% to -$182.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $516.6 million, marking a year-over-year increase of 11214.54%. This contributed to the annual value of -$2.1 billion for FY2024, which is 1928.28% up from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Change in Cash is -$182.5 million, which was up 7893.67% from $77.9 million recorded in Q2 2025.
  • BioNTech SE's Change in Cash's 5-year high stood at $4.1 billion during Q3 2022, with a 5-year trough of -$2.9 billion in Q1 2024.
  • For the 5-year period, BioNTech SE's Change in Cash averaged around $285.6 million, with its median value being $77.9 million (2025).
  • As far as peak fluctuations go, BioNTech SE's Change in Cash surged by 7523489418.59% in 2022, and later plummeted by 3698873.07% in 2023.
  • Over the past 5 years, BioNTech SE's Change in Cash (Quarter) stood at -$818.4 in 2021, then skyrocketed by 75234894.19% to $615.7 million in 2022, then crashed by 424.52% to -$2.0 billion in 2023, then soared by 107.28% to $145.4 million in 2024, then tumbled by 225.48% to -$182.5 million in 2025.
  • Its last three reported values are -$182.5 million in Q3 2025, $77.9 million for Q2 2025, and $475.8 million during Q1 2025.